Moderna, Inc. NMS · MRNA
Price alert —
Sign in to get a one-time email the moment MRNA crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · MRNA
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.4B | $-1.3B | $-1.4B | $-0.7B | -345.2% | -356.8% |
| 2025-12-31 | $0.7B | $-0.8B | $-0.9B | $0.9B | -122.2% | -126.8% |
| 2025-09-30 | $1.0B | $-0.2B | $-0.3B | $-0.9B | -20.0% | -25.9% |
| 2025-06-30 | $0.1B | $-0.8B | $-0.9B | $-0.9B | -602.2% | -662.0% |
| 2025-03-31 | $0.1B | $-1.0B | $-1.1B | $-1.2B | -907.5% | -981.3% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare MRNA vs peers
Line MRNA up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
MRNA
Moderna, Inc.
$61.82
-2.11%
LLY
LLY
$1179.11
+0.85%
UNH
UnitedHealth Group Incorporated
$426.09
+0.64%
Earnings replay · last 0 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
No earnings history available.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| MRNA ★ | $25B | — | -15.0 | 11.0 | -9.0 | 3.3 | -69.9% | 260.2% | — | -0.08% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 48.98%
| Holder | Shares | % out |
|---|---|---|
| FMR, LLC | 45,672,024 | 11.51% |
| Blackrock Inc. | 29,635,876 | 7.47% |
| Vanguard Capital Management LLC | 22,872,458 | 5.76% |
| BAILLIE GIFFORD & CO | 19,985,876 | 5.04% |
| Capital World Investors | 18,697,694 | 4.71% |
| Vanguard Portfolio Management LLC | 15,616,367 | 3.94% |
| State Street Corporation | 14,861,409 | 3.75% |
| Geode Capital Management, LLC | 9,435,132 | 2.38% |
| Two Sigma Investments, LP | 9,086,404 | 2.29% |
| Morgan Stanley | 8,471,263 | 2.13% |
Insider activity · 90d
5 buys / 0 sells · ratio 5.0 · Finnhub
- McDonnell Michael R. BUY 5,733
- McDonnell Michael R. BUY 1,618
- McDonnell Michael R. BUY 7,415
- Banque Soria Ester BUY 38,364
- Banque Soria Ester BUY 18,658
- Mock James M M 1,454
- Mock James M F 66,436 @ $72.50
- Mock James M M 67,139
- Klinger Shannon Thyme M 117,976
- Klinger Shannon Thyme F 73,561 @ $51.59
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
No CIK found for MRNA.
About MRNA
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name t…
Options picks · MRNA
ITM + OTM ideas from the latest scanLoading…
Congress trades · MRNA
STOCK Act disclosuresLoading…
SEC filings & insiders · MRNA
EDGAR · liveLoading…
Holders · MRNA
Institutions & insider activityLoading…